Dr. Melissa A. Wilson
Claim this profileSt. Lukes University Health Network
Studies Melanoma
Studies Cutaneous Melanoma
5 reported clinical trials
9 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
BRAF positive
2Cutaneous Melanoma
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Melissa A. Wilson is currently running
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
Neoadjuvant Daromun + Surgery
for Melanoma
The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Recruiting2 awards Phase 318 criteria
More about Melissa A. Wilson
Clinical Trial Related10 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Melissa A. Wilson has experience with
- Nivolumab
- Adjuvant Therapy
- Daromun
- Surgery
- CMP-001
- Pembrolizumab
Breakdown of trials Melissa A. Wilson has run
Melanoma
Cutaneous Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melissa A. Wilson specialize in?
Melissa A. Wilson focuses on Melanoma and Cutaneous Melanoma. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Melissa A. Wilson currently recruiting for clinical trials?
Yes, Melissa A. Wilson is currently recruiting for 3 clinical trials in Easton Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Melissa A. Wilson has studied deeply?
Yes, Melissa A. Wilson has studied treatments such as Nivolumab, Adjuvant therapy, Daromun.
What is the best way to schedule an appointment with Melissa A. Wilson?
Apply for one of the trials that Melissa A. Wilson is conducting.
What is the office address of Melissa A. Wilson?
The office of Melissa A. Wilson is located at: St. Lukes University Health Network, Easton, Pennsylvania 18045 United States. This is the address for their practice at the St. Lukes University Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.